TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 55 filers reported holding TELA BIO INC in Q1 2023. The put-call ratio across all filers is 2.83 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,697,400 | -33.8% | 337,175 | -16.1% | 0.51% | -5.4% |
| Q2 2023 | $4,072,422 | +2.9% | 402,016 | +8.1% | 0.54% | +34.8% |
| Q1 2023 | $3,956,048 | -33.9% | 371,809 | -28.5% | 0.40% | +29.4% |
| Q4 2022 | $5,980,909 | +35.0% | 520,079 | 0.0% | 0.31% | +20.7% |
| Q3 2022 | $4,431,000 | +13.8% | 520,079 | -6.4% | 0.26% | +13.3% |
| Q2 2022 | $3,895,000 | -41.0% | 555,623 | -2.1% | 0.23% | +5.6% |
| Q1 2022 | $6,599,000 | -8.6% | 567,420 | +0.6% | 0.21% | -18.3% |
| Q4 2021 | $7,221,000 | -8.9% | 564,120 | -2.8% | 0.26% | +8.7% |
| Q3 2021 | $7,930,000 | -35.0% | 580,515 | -23.4% | 0.24% | -36.6% |
| Q2 2021 | $12,204,000 | +94.5% | 757,524 | +79.8% | 0.38% | +112.3% |
| Q1 2021 | $6,276,000 | +34.9% | 421,202 | +36.2% | 0.18% | +5.9% |
| Q4 2020 | $4,652,000 | -2.6% | 309,323 | +7.2% | 0.17% | -31.3% |
| Q3 2020 | $4,774,000 | – | 288,605 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,565,709 | $24,996,000 | 10.33% |
| Opaleye Management Inc. | 1,643,367 | $11,520,000 | 5.19% |
| INDUSTRY VENTURES, L.L.C. | 579,745 | $4,064,000 | 4.31% |
| Velan Capital Investment Management LP | 498,238 | $3,493,000 | 3.54% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 116,095 | $825,000 | 0.83% |
| HAMILTON LANE ADVISORS LLC | 264,366 | $1,853,000 | 0.72% |
| AIGH Capital Management LLC | 306,464 | $2,156,000 | 0.57% |
| Worth Venture Partners, LLC | 113,012 | $904,000 | 0.53% |
| Granite Point Capital Management, L.P. | 227,644 | $1,596,000 | 0.41% |
| Orbimed Advisors | 3,027,542 | $21,223,000 | 0.38% |